U.S. Patent Office Upholds StemCells’ Patents – Company Moves to …
PALO ALTO, Calif. – (Business Wire) StemCells, Inc. (NASDAQ:STEM) announced today that the U.S. Patent and Trademark Office (PTO) has upheld the validity of the remaining two neural stem cell patents which were subjected to reexamination proceedings …
[Read the full article here]Related News:
StemCells, Inc. Strengthens Patent Position in Embryonic and Induced Pluripotent Stem Cell Technology Platforms
International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office
International Stem Cell Corporation’s Parthenogenetic Stem Cell Patent is Approved by the United States Patent and …